This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
atrialfibrillation (AF), a heart condition that causes an irregular heartbeat in the upper chambers of the heart, affects up to one in three people in their lifetime. Significant complications associated with this condition include ischemic stroke, heart failure, myocardial infarction, chronic kidney disease, dementia and mortality.
BackgroundNon-valvular atrialfibrillation (NVAF) significantly increases ischemic stroke and systemic embolism (SE) risks. OAC users predominantly had cardiovascular disease and risk factors, whereas non-OAC users had higher rates of malignancy and dementia. Early OAC initiation (74.9% for all-cause, p-value<0.001 and 1.3%
Three common cardiovascular diseases in adults—heart failure, atrialfibrillation and coronary heart disease—are linked to cognitive impairment and increased risk of dementia, according to "Cardiac Contributions to Brain Health," a new scientific statement from the American Heart Association published today in the journal, Stroke.
Atrialfibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. This irregular heartbeat is associated with increased risks of heart failure, dementia and stroke. It constitutes a significant burden to healthcare systems, making its early detection and treatment a major goal.
Cardiogenic dementia is a cognitive impairment caused by heart dysfunction and has received increasing research attention. The prevention and treatment of cardiogenic dementia are essential to improve the quality of life, particularly in the elderly and aging population.
Atrialfibrillation is the most common types of cardiac arrhythmia. At the same time, Alzheimer’s disease and other dementias represent a significant global health burden, with an estimated prevalence of 51.6 Observational studies showed the AF is associated with an increased risk of dementia, as well as cognitive impairment.
Atrialfibrillation (AF) is associated with the development of dementia and observational studies have shown that oral anticoagulation (OAC) and catheter ablation reduce dementia risk.
Atrialfibrillation (AF) is a common form of heart arrhythmia, a serious condition in which the heart beats so fast that its upper chambers, the atria, quiver. This irregular heartbeat can increase the risk of severe conditions, including heart failure, dementia and stroke.
AF stands for atrialfibrillation. There was a study in 2009 called the Intermountain Heart collaborative study which evaluated 37000 patients and followed them for development of AF and dementia and found that patients with AF were 44% more likely to develop dementia compared to patients without AF.
million Americans have atrialfibrillation. Atrialfibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.
Catheter ablation (CA) of atrialfibrillation (AF) has been proved to benefit patient with symptomatic AF and heart failure. However, the data on neurological outcomes including cerebrovascular disease (CVA) and dementia remain a controversy.
Atrialfibrillation, a common consequence of high blood pressure in Western populations, is almost unheard of in the Tsimane Tribe. Dementia Up to 40% of dementia cases could be prevented by focusing on modifiable risk factors 11. In most Western populations, dementia consistently ranks as a leading cause of death.
Abstract Atrialfibrillation (AF) is currently defined as symptomatic by asking patients if they are aware of when they are in AF and if they feel better in sinus rhythm. Labeling these patients as asymptomatic falsely suggests that their AF requires less intense therapy and puts into question the notion of truly asymptomatic AF.
The burden of neurologic diseases, including stroke and dementia, is expected to grow substantially in the coming decades. This scientific statement discusses the pathogenic mechanisms that link 3 prevalent cardiac diseases of adults (heart failure, atrialfibrillation, and coronary heart disease) to cognitive impairment.
ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke, heart failure, dementia, and hospitalization. Journal of the American Heart Association, Ahead of Print.
After adjusting for gender, age and left ventricle ejection fraction, the results showed that the risk of death was higher in patients with dementia, higher levels of plasma creatinine (PCr), lower levels of platelet distribution width (PDW) and at Q4 of red cell distribution width (RDW).
million Americans have atrialfibrillation. Atrialfibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.
Background:The aging of the population is associated with an increasing number of stroke patients with pre-existing dementia. However, the association between pre-stroke dementia and functional outcome after acute ischemic stroke (AIS) has not been fully investigated. women), 86 (17.4%) had PED.
Cardiovascular disease, cancer and dementia account for 60% of all deaths in the US. For those in the ‘Ideal’ category, they were 51% less likely to have either dementia or depression. And less diabetes means less of a driver of the three main leading causes of death - cardiovascular disease, cancer and dementia.
The most common etiologies of 90‐day readmission among diabetics were cardiovascular (28.98%), neurological (12.92%), and infectious (7.72%).ConclusionDiabetics ConclusionDiabetics had higher 90‐day readmission following TIA than non‐diabetics.
Insulin resistance is a core risk factor for the three leading causes of death: Cardiovascular Disease Cancer Dementia. Insulin resistance is unlikely to be the primary causal factor for these conditions but is likely to be a major accelerant. Subscribe now Take cardiovascular disease, for example.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrialfibrillation (AF). link] ACC/AHA Release Updated AtrialFibrillation Guidelines for 2023. million. Sources: Joglar, J, Chung, M. J Am Coll Cardiol.
ABSTRACT Background Atrialfibrillation (AF) and dementia are increasingly prevalent in aging US populations. This study examines AF and dementia-related mortality trends from 2000 to 2020. Results A total of 400103 AF and dementia-related deaths were recorded between 2000 and 2020. in 2000 to 70.4 p <0.001).
Atrialfibrillation is the most common heart rhythm disorder in adults, affecting more than 5 million people in the U.S., The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of AtrialFibrillation noted that abstaining from caffeine to prevent heart rhythm disturbances is of no benefit to people with AFib.
Objective To evaluate adherence and adherence consistency to the handheld ECG device-based screening protocol and their association with adverse cerebral and cardiovascular outcomes in two systematic atrialfibrillation (AF) screening programmes. to 2.32), p=0.001) and dementia (1.67 (1.27 to 2.19), p<0.001).
Background:Aged heart failure (HF) patients without dementia have a risk of cognitive impairment (CI) that attenuates the effect of treatment for HF. We excluded patients with dementia using mini-mental state examination. Circulation, Volume 150, Issue Suppl_1 , Page A4140001-A4140001, November 12, 2024. 0.63, P=0.01).
Background:Catheter ablation (CA) is increasingly used for treatment of atrialfibrillation (AF). years; 55% female, 28% frailty, 13% dementia), including 8% receiving CA. Circulation, Volume 150, Issue Suppl_1 , Page A4141439-A4141439, November 12, 2024. However, CA has not been widely adopted in the older population with AF.
Introduction:Atrial fibrillation (AF) has been linked to cognitive impairment and dementia (CID) even among patients without clinically obvious stroke, but the mechanism is not established. Patients with a diagnosis of mild cognitive impairment or dementia were classified as having CID.
Those with high mRS were more likely to have high school-only education or a diagnosis of dementia on admission compared to those with low mRS. Those with high school-only education were 2.94 Similarly, those with a diagnosis of dementia on admission, were 6.22 Similarly, those with a diagnosis of dementia on admission, were 6.22
The median time between comorbidity and HF diagnoses ranged from depression preceding HF by 10.7years to dementia proceeding HF by 0.7years; all comorbidities presented earlier in women. In all age strata, comorbidities accumulated for over a decade before HF and this accelerated in the years immediately before HF.
Different forms of cardiac disease have also been associated with cognitive impairment and dementia. Background:Previous reports have established a relationship between asymptomatic high-grade carotid artery stenosis (CAS) and impaired cognition. The effect of concurrent high-grade CAS and cardiac disease on cognition is unknown.
We used a mixed effects linear regression model to examine the relationship between DTD group and length of stay, controlling for age, race, sex, last known well to arrival time, initial NIHSS, atrialfibrillation, and alcohol/drug abuse and clustering by hospital site.
Negative predictors included dementia, pacemaker, coronary revascularization, and cerebrovascular disease. Positive predictors of 7-day cardiac outcomes included age greater than 60 years , male gender, congestive heart failure , ischemic heart disease , cardiac arrhythmia , and valvular heart disease.
Atrialfibrillation (AF) is the most frequent heart rhythm disorder worldwide with a prevalence of 1%2% in general population. It is associated with increased mortality and morbidity, including increased risk of dementia. In addition to cognitive impairment, AF has been related to anxiety and mood disorders.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content